Abbott Laboratories
BMV:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
|
Fastbase Inc
OTC:FBSE
|
US |
|
B-R 31 Ice Cream Co Ltd
TSE:2268
|
JP |
|
A
|
Actoz Soft Co Ltd
KOSDAQ:052790
|
KR |
Wall Street
Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABT
is 2 362.62 MXN
with a low forecast of 1 989.81 MXN and a high forecast of 2 892.39 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABT's stock price target?
Price Target
2 362.62
MXN
According to Wall Street analysts, the average 1-year price target for
ABT
is 2 362.62 MXN
with a low forecast of 1 989.81 MXN and a high forecast of 2 892.39 MXN.
What is Abbott Laboratories's Revenue forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Abbott Laboratories's revenue is
5%.
The projected
CAGR
for the next 3 years is
8%.
What is Abbott Laboratories's Operating Income forecast?
Projected CAGR
18%
For the last 14 years the
compound annual growth rate for
Abbott Laboratories's operating income is
13%.
The projected
CAGR
for the next 3 years is
18%.
What is Abbott Laboratories's Net Income forecast?
Projected CAGR
23%
For the last 14 years the
compound annual growth rate for
Abbott Laboratories's net income is
2%.
The projected
CAGR
for the next 3 years is
23%.
